FDA Approves Durvalumab for Treatment of Adults Patients With LS-SCLC
Published: December 5th 2024 | Updated: December 5th 2024The indication is for adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed after platinum-based chemotherapy and radiation therapy.
Read More
Shaping the Future of Pharmacy: Trends to Watch at ASHP Midyear 2024
December 4th 2024Key trends shaping the future of health-system pharmacy include advanced medication management to address supply chain challenges, digital transformation to enhance pharmacy operations, and strategies for compliance with evolving regulations, all of which will be central topics at the ASHP Midyear 2024 meeting.
Read More
The Power of Our Voice: Why Pharmacists Must Advocate for Our Profession
December 4th 2024Advocacy ensures that policymakers understand the realities on the ground. If we fail to speak up, decisions about our profession will be made without our input—often by individuals who lack the expertise and perspective we bring to the table.
Read More